move sidelin
ew
continu believ alexion repres one
signific disconnect intrins current valu
also believ management organ plan drive pipelin expans
unlik close gap near-term inorgan action
remain biggest risk ew
downgrad ew despit strong management execut long-term valu
fundament view alexion busi remain larg unchang
continu believ management effect transit soliri ultomiri
maintain larg emerg neurolog franchis despit potenti
competit mechan said major overhang
concentr risk remain one believ address
near-term management effect expand busi develop effort
diversifi busi acquir product drive near-term
revenu diversif thu view management sustain
base busi posit believ management disprov neg
biosimilar launch face signific eros engag
much sizeabl off-set larg franchis close
gap intrins market valu
key catalyst includ updat competit data earli stage pipelin
readout expect data potenti competit product
regeneron novarti cover mark purcel appelli cover
drive sentiment view data stealth elamipretid
management option right achillion factor inhibitor initi affibodi
data increment driver potenti increas investor optim around
base busi diversif also look forward initi ultomiri sub-
chang model lower long-term franchis sale
better account potenti biosimilar competit beyond also
updat forecast better reflect view management need invest
busi near-to-medium term prosecut expand pipelin
 unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
ultomiri share convers soliris/strensiq/kanuma sale growth drive
ultomiri share convers soliris/strensiq/kanuma sale growth drive
equal-weight believ
current valuat impli manag
unabl grow busi
overlook share shift potenti
ultomiri even conserv scenario
assum ultomiri achiev solid
profil assum either market share
price pressur year
assum strensiq achiev
meaning sale see modest sale
key revenu driver model
continu ahu pnh sale growth
franchis coupl growth
soliri mg success share shift
risk achiev price
soliri pnh ahu mg growth could fail
meet expect
strensiq and/or kanuma fail captur
share convers soliri ultomiri
project
could potenti bad
behavior identifi commerci
deriv pt discount cash flow analysi assum
wacc termin growth rate revenu
driver model pnh sale ahu sale mg sale nmo sale
strensiq sale kanuma sale incorpor cash cost
diagnost algorithm drive sustain pnh ahu mg penetr
ultomiri succe signific share convers bull case assum
soliri becom standard care pnh ahu nmo mg pnh
sale peak ww ahu sale peak
assum strensiq kanuma continu launch sale
respect
soliri meaning growth pnh ahu gmg ultomiri succe
modest share convers base case assum solid convers ultomiri
long-term durabl complement franchis assum gmg
nmo meaning contribut sale assum strensiq kanuma
continu launch sale respect
see soliri longev incorpor competit price pressur
soliri face signific competit strensiq kanuma achiev minim
sale bear case assum soliri fail gain label expans soliri
face signific headwind biosimilar proprietari competit
diversif strensiq kanuma minim
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report matthew
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
novemb benefici own class common equiti secur follow compani cover
within last month manag co-manag public offer offer secur alector inc
within last month receiv compens invest bank servic alector inc aprea
next month expect receiv intend seek compens invest bank servic akebia
within last month receiv compens product servic invest bank servic amgen inc
within last month provid provid invest bank servic invest bank client relationship
follow compani alector inc amgen inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amgen inc beigen ltd biogen inc biomarin
 co llc make market secur alector inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
use rel rate system use term overweight equal-weight not-rat underweight see definit morgan
stanley assign rate buy hold sell stock cover overweight equal-weight not-rat underweight equival
buy hold sell investor care read definit rate use morgan stanley research addit sinc morgan stanley research
contain complet inform concern analyst view investor care read morgan stanley research entireti infer
content rate alon case rate research use reli upon invest advic investor decis buy sell
stock depend individu circumst investor exist hold consider
novemb
stock rate describ appli fundament equiti research appli debt research produc firm
disclosur purpos accord nasd nyse requir includ categori head buy hold sell alongsid
rate overweight equal-weight not-rat underweight assign rate buy hold sell stock cover
overweight equal-weight not-rat underweight equival buy hold sell repres recommend rel weight see
definit satisfi regulatori requir correspond overweight posit stock rate buy recommend correspond
equal-weight not-rat hold underweight sell recommend respect
data includ common stock adr current assign rate invest bank client compani receiv invest
bank compens last month due round decim percentag provid total column may add exactli
overweight stock total return expect exceed averag total return analyst industri industri team coverag univers
risk-adjust basi next month
equal-weight stock total return expect line averag total return analyst industri industri team coverag univers
risk-adjust basi next month
not-rat nr current analyst adequ convict stock total return rel averag total return analyst
industri industri team coverag univers risk-adjust basi next month
underweight stock total return expect averag total return analyst industri industri team coverag univers
risk-adjust basi next month
unless otherwis specifi time frame price target includ morgan stanley research month
attract analyst expect perform industri coverag univers next month attract vs relev broad
market benchmark indic
in-lin analyst expect perform industri coverag univers next month line relev broad market
benchmark indic
cautiou analyst view perform industri coverag univers next month caution vs relev broad market
benchmark indic
benchmark region follow north america latin america relev countri index latin america index europ
europ japan topix asia relev countri index sub-region index ac asia pacif ex japan index
stock price price target rate histori rate definit
import disclosur morgan stanley smith barney llc custom
